• sns01
  • sns02
  • sns02-2
  • I-YouTube1
isibhengezo_sekhasi

izindaba

Ingabe i-tirzepatide ingcono kune-semaglutide?

Isebenza kanjani i-tirzepatide ne-semaglutide?

Njengomjovo we-weightloss odumile, i-Semaglutide ne-Tirzepatide zisebenza ngokunciphisa isifiso sokudla.Izinguquko ekudleni nasekuzivivinyeni ngokuvamile zihlanganiswa nale mithi.

I-Semaglutideiyi-agonist efana ne-glucagon-like peptide-1 (GLP-1), okusho ukuthi ilingisa ihomoni ye-GLP-1 futhi ikwenza uzizwe ungalambi kangako. dala i-insulin eningi.Ingase futhi ithumele izimpawu zokugcwala ebuchosheni.

I-Tirzepatidefuthi okuthiwa Mounjaro.Kokubili i-insulinotropic polypeptide (GIP) encike ku-glucose kanye ne-GLP-1 receptor agonist.I-Tirzepatide ilingisa Umthombo Othenjwayo i-hormone ye-GLP-1 kanye ne-hormone ye-GIP.I-hormone ye-GIP ingase futhi ibangele ukwakhiwa kwe-insulin kanye nomuzwa wokugcwala.

I-weightloss injection isebenza umzila

Imithamo nemiphumela?

Umthamo uzohluka ezigulini ezihlukene.Landela imiyalo kadokotela wakho noma izikhombisi-ndlela ezikulebula.Ulwazi olulandelayo luhlanganisa kuphela imithamo eyisilinganiso .Uma umthamo wakho uhlukile, ungawushintshi ngaphandle uma udokotela wakho ekutshela ukuthi wenze njalo.
Imithamo ye-Tirzepatide
Umthamo wokuqala: 2.5 mg ngaphansi kwesikhumba kanye ngesonto
Ngemuva kwamaviki ama-4: Umthamo kufanele unyuswe ube ngu-5 mg ngaphansi kwesikhumba kanye ngesonto.
Ukuze uthole ukulawulwa okwengeziwe kwe-glycemic: Khulisa umthamo ngo-2.5 ​​mg increments ngemva kwamaviki okungenani ama-4 kumthamo wamanje.
Umthamo omkhulu: 15 mg ngaphansi kwesikhumba kanye ngesonto
I-Semaglutide 5 mg
I-Methylcobalamin 0.2mg/mL
(2mL usayizi wevial)
• Isonto 1 kuya kwelesi-4 : Jova
5 amayunithi (0.25mg/0.05mL) kanye ngesonto
• Isonto lesi-5 kuya kwelesi-8: Jova
Amayunithi ayi-10 (0.5mg/0.1mL) kanye ngesonto
• Isonto 9 kuya kwele-12: Jova
Amayunithi angama-20 (1mg/0.2mL) kanye ngesonto
• Isonto 13 kuya kwele-16: Jova
Amayunithi angama-34 (1.7mg/0.34mL) kanye ngesonto
• Isonto le-17 kuqhubeke: Jova amayunithi angama-48
(2.4mg/0.48mL) kanye ngesonto

Ukusebenzisa i-tirzepatide kubangele ukulahlekelwa kwesisindo se-17.8% (95% CI: 16.3% -19.3%) uma kuqhathaniswa ne-12.4% (95% CI: 11.5% -13.4%) ye-semaglutide.

Iziphetho: I-Tirzepatide inikeza inani elingcono lemali kune-semaglutide yokunciphisa isisindo.

ukuncipha kwesisindo ngaphambi nangemuva

IF Izindleko ze-Tirzepatideephakeme kunaleIzindleko ze-Semgalutide?futhi iyiphi edume kakhulu e-USA nase-UK?

Enye i-Weightloss injection peptide sicela uhlole

https://www.lianfu-pharm.com/

 

 

 


Isikhathi sokuthumela: Nov-18-2023